PG-003BDNF Alternative Peptide (TrkB Agonist)

Fully-Chemically Synthesized Peptide with Activity Equivalent to BDNF

Like growth factor BDNF, PG-003 is a growth factor alternative peptide with agonistic activity against the TrkB receptor. In the field of regenerative medicine and cell therapy for the nervous system, which has been extensively researched and developed in recent years, BDNF Alternative Peptide can be used in maintaining the survival and inducing differentiation of nervous system cells.

Induces Dimerization of TrkB and Exerts Biological Activity similar to BDNF

*This is for illustrative purpose.

We performed a functional comparison test between our BDNF Alternative Peptide (PG-003) and commercially available recombinant BDNF.
From the results, PG-003 showed the property which promotes the phosphorylation of TrkB receptor and the expression of NFAT-responsive reporter gene at the same level per molecule compared with recombinant BDNF.
The molecular weight of TrkB agonist peptide is approximately 5.1 kDa, which is approximately 2.5 times smaller than that of recombinant BDNF.

PG-003 Product Overview

Formulation	Lyophilized
Storage Condition	≦-20℃
Purity	≧95% (HPLC)
Molecular Weight	5151.66 (Acetate)
Product Size (Quantity equivalent to recombinant BDNF)	10µg per a glass vial (Equivalent to recombinant BDNF Approx. 25µg)

Sample Requests and Purchases of Our Products

For inquiries regarding growth factor-substituting peptides, please contact the CONTACT Inquiry Form or the following sales agents. In addition to testing and research purpose, we are also able to provide GMP-compliant products that can be supplied in bulk shipments, and used to manufacture regenerative medicine and cell therapy.